Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer’s disease

被引：0
|
作者：
Min Liu
Haibiao Guo
Chuyuan Li
Deqin Wang
Jingang Wu
Canmao Wang
Jiangping Xu
Ren-an Qin
机构：
[1] Modern Chinese Medicine Research Institute of Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co.,Department of Pharmacology, School of Pharmaceutical Sciences
[2] Ltd.,Post Doctoral Scientific Research Center
[3] Southern Medical University,undefined
[4] Guangzhou Pharmaceutical Corporation,undefined
来源：
BMC Complementary and Alternative Medicine | / 15卷
关键词：
Alzheimer’s disease; Compound danshen; Insulin-degrading enzyme (IDE); Neprilysin (NEP);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effect of Hesperidin Extraction on Cell Proliferation and Apoptosis of Alzheimer's Disease Induced by Aβ25-35
    Luo, Xiaoting
    Huang, Qin
    Li, Shumei
    Li, Sisi
    Xiong, Liang
    Dong, Minghua
    2010 3RD INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI 2010), VOLS 1-7, 2010, : 2020 - 2023
  • [22] The modulatory role of phloretin in Aβ25–35 induced sporadic Alzheimer’s disease in rat model
    Priya J. Ghumatkar
    Sachin P. Patil
    Vaibhavi Peshattiwar
    Tushara Vijaykumar
    Vikas Dighe
    Geeta Vanage
    Sadhana Sathaye
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392 : 327 - 339
  • [23] Mesenchymal stem cells after the proprocessing of tanshinone IIA attenuate cognitive deficits and oxidative stress injury in an amyloid β-peptide (25-35)-induced rodent model of Alzheimer's disease
    Ba, Zhisheng
    Shi, Shangpeng
    Huang, Nanqu
    Li, Yuanyuan
    Huang, Juan
    You, Chao
    Yang, Xiaoyan
    Liu, Daishun
    Yu, Changyin
    He, Yuqi
    Luo, Yong
    NEUROREPORT, 2022, 33 (02) : 61 - 71
  • [24] Interaction between Alzheimer's Aβ(25-35) peptide and phospholipid bilayers: The role of cholesterol
    D'Errico, Gerardino
    Vitiello, Giuseppe
    Ortona, Ornella
    Tedeschi, Annamaria
    Ramunno, Anna
    D'Ursi, Anna Maria
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2008, 1778 (12): : 2710 - 2716
  • [25] Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease
    Li, Lin
    Xu, Shaofeng
    Liu, Lifei
    Feng, Rentian
    Gong, Yongxiang
    Zhao, Xuyang
    Li, Jiang
    Cai, Jie
    Feng, Nan
    Wang, Ling
    Wang, Xiaoliang
    Peng, Ying
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 56 (04) : 1403 - 1416
  • [26] NOOTROPIC ACTIVITY OF ISORHAMNETIN IN AMYLOID BETA 25-35 INDUCED COGNITIVE DYSFUNCTION AND ITS RELATED mRNA EXPRESSIONS IN ALZHEIMER'S DISEASE
    Asha, Deivasigamani
    Sumathi, Thangarajan
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (08): : 3233 - 3242
  • [27] The modulatory role of phloretin in A25-35 induced sporadic Alzheimer's disease in rat model
    Ghumatkar, Priya J.
    Patil, Sachin P.
    Peshattiwar, Vaibhavi
    Vijaykumar, Tushara
    Dighe, Vikas
    Vanage, Geeta
    Sathaye, Sadhana
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (03) : 327 - 339
  • [28] Interaction of Alzheimer's disease amyloid β peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain
    Pérez, M
    Cuadros, R
    Benítez, MJ
    Jiménez, JS
    JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (05) : 461 - 467
  • [29] Antidepressant-Like Effect of RoprenA® in β-Amyloid-(25-35) Rat Model of Alzheimer's Disease with Altered Levels of Androgens
    Soultanov, Vagif
    Fedotova, Julia
    Nikitina, Tamara
    Roschin, Victor
    Ordyan, Natalia
    Hritcu, Lucian
    MOLECULAR NEUROBIOLOGY, 2017, 54 (04) : 2611 - 2621
  • [30] Autoimmune responses to amyloid structures of Aβ(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease
    Grudena, MA
    Davudova, TB
    Malisauskas, M
    Zamotin, VV
    Sewell, RDE
    Voskresenskaya, NI
    Kostanyan, IA
    Shrestnev, VV
    Morozova-Roche, LA
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (02) : 165 - 171
12345